News & Analysis

Biotechnology & Biopharmaceutical Industry News, Analysis and Commentary.

October 16, 2017

Evotec Invests €15m in Exscientia in Latest Partnership between Big Pharma & Artificial Intelligence-Driven Drug Discovery

[vc_row][vc_column][vc_column_text] German pharmaceutical company Evotec has expanded its partnership with Scottish artificial intelligence drug design pioneers Exscientia, investing a further €15m in exchange for a minority […]
October 5, 2017

2017 Global Therapeutic IPO Market: 121% YOY Increase in Funds Raised Despite Slow Q3

[vc_row][vc_column][vc_column_text] The global therapeutic IPO market has failed to maintain the upward momentum established throughout a busy Q2 2017, with just over $1B raised by 13 […]
August 31, 2017

The CAR-T Revolution: Gilead’s $12B Acquisition of Kite Pharma & FDA Approval of Novartis’ Kymriah Signal Tipping Point for Promising Cancer Immunotherapies

[vc_row][vc_column][vc_column_text] Gilead Sciences has ended its M&A moratorium with an $11.9B all-cash acquisition of CAR-T Cell Therapy pioneers Kite Pharma. Kite’s leading drug Axi-Cel is expected […]
August 22, 2017

Exploring the History & Viability of Xenotransplantation: Porcine Retroviruses, CRISPR Off-Target Effects, Immune Rejection & Regulatory Hurdles

[vc_row][vc_column][vc_column_text]Scientists at e-Genesis, a Massachusetts-based biotech firm, recently announced that they have successfully utilised CRISPR gene-editing technology to inactivate Porcine Endogenous Retroviruses (PERVs) in a line […]
May 23, 2017

Thermo Fisher Continues Vertical Integration with $7.2B Acquisition of CDMO Patheon

[vc_row][vc_column][vc_column_text] Dutch Contract Development & Manufacturing Organisation Patheon has been acquired by Thermo Fisher Scientific in a $7.2B deal. The acquisition, which includes the assumption of […]
April 12, 2017

GE Healthcare Adds to Its Cell Therapy Portfolio with Acquisition of Asymptote

[vc_row][vc_column][vc_column_text]GE Healthcare recently announced the acquisition of British cryogenic processing company Asymptote for an undisclosed price, strengthening its cell therapy portfolio with technologies designed to enable […]
April 4, 2017

Singulex Announces CE Marking for Sgx Clarity® System & Expands Collaboration with European Clinical Laboratories

[vc_row][vc_column][vc_column_text] California-based Immunodiagnostics company Singulex have announced that they have received CE marking for the Sgx Clarity® system, a fully-automated IVD platform powered by the company’s […]